ClinicalTrials.Veeva

Menu

Submacular Hemorrhage Associated With Retinal Arterial Macro Aneurysm

K

Kyorin University

Status

Completed

Conditions

Ruptured Retinal Arterial Macro Aneurysms
Submacular Hemorrhage

Treatments

Procedure: Vitrectomy for submacular hemorrhage
Drug: subretinal injection of tissue-plasminogen activator

Study type

Interventional

Funder types

Other

Identifiers

NCT02120066
Kyorineye015

Details and patient eligibility

About

Evaluation of surgical outcome of vitrectomy with subretinal injection of recombinant tissue-plasminogen activator for submacular hemorrhage associated with retinal arterial macroanuerysms.

Enrollment

22 patients

Sex

All

Ages

40 to 95 years old

Volunteers

No Healthy Volunteers

Inclusion criteria

  • The patients with sub macular hemorrhage associated with ruptured retinal arterial macro aneurysms

Exclusion criteria

  • The eyes with preretinal or intraretinal hemorrhage at the fovea
  • The patients with follow-up less than 3 months

Trial design

Primary purpose

Treatment

Allocation

N/A

Interventional model

Single Group Assignment

Masking

None (Open label)

22 participants in 1 patient group

Vitrectomy
Other group
Treatment:
Procedure: Vitrectomy for submacular hemorrhage
Drug: subretinal injection of tissue-plasminogen activator

Trial contacts and locations

1

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems